
About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.

About 1 in 10 individuals in the United States have diabetes. A recent study examines how much they are paying on average for access to treatment for the common disease.

Survey respondents indicated a lack of comfort around recommending psilocybin therapy to patients.

New research examines how individuals with continuing COVID-19 symptoms are managing the virus.

Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.

The 2023 AAP Annual Conference will take place in New Orleans from April 20 to 22.

As sessions end for the day, head out to explore the city of Phoenix.

APhA 2023 will take place March 24 to March 27 in Phoenix, Arizona

To sufficiently address HIV, stakeholders across the health care spectrum must come together.

Take a look back at our most popular conference coverage for 2022.

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures.

When dealing with marginalized and underserved populations, it is important to understand barriers to care and why they exist.

With increasing use of telehealth, patients need access to resources that let them get the most out of the experience.

Drug Topics® talks to Trent Theide, president of PASS National, on tackling PBM audits.

The Fall 2022 summit tackled adding new revenue streams, upcoming legislation, and the expansion of pharmacy.

New pathways of care are needed to improve health care spending.

Social support and education may be the solution.

Haylea Hannah, MSPH, PhD, discusses her research on the barriers to medications for opioid use disorder that people who are incarcerated can face and what pharmacists can do to address the barriers.

Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.

A group of pharmacists rose to the occasion to help a man having a medical emergency aboard a recent United flight bound for Newark, New Jersey.

The U.S. biosimilar landscape is changing, and legislation may be the key to controlling drug prices and advancing the market.

Knowledge gaps can make OTC medication recommendations for this population a challenge.

Low-income subsidies can eliminate much of the out-of-pocket costs that patients must pay.

Direct-to-consumer companies attract attention on social media, but are they as effective as traditional healthcare services?

Not every pharmacist may feel comfortable administering vaccines to children, but education could help.

Pharmacists can optimize medication adherence and serve as an additional touchpoint for patients during treatment.

Two clinical pathways were created to manage patients and required resources.

Diabetes self-management education and diabetes prevention programs can improve patient outcomes including mental health and HbA1C.

Biosimilars have the potential to create immense savings.

Developing more advanced roles for pharmacy technician can reduce turnover in roles.